
Intelligent Field Excellence Platform for Life Sciences | ACTO
ACTO makes it easy for field-based teams to review and remember brand and clinical messages with key takeaways from training, talk tracks for core visual aids, and tips from coaching.
Our Story | A New Vision | ACTO
Since our inception in 2014, ACTO has grown into a global Life Sciences SaaS provider headquartered in Toronto, Canada. Learn more about our history and mission.
About Us | ACTO
ACTO's mission is to help biopharmaceutical and medical device companies improve patient outcomes as they introduce therapies to market.
AI-Powered Intelligent Field Excellence Platform - ACTO
ACTO is your all-in-one platform for empowering field professionals to excel in every HCP interaction. From training and certification to coaching, practice, and real-time field …
Careers at ACTO | ACTO
Join ACTO to help transform the world’s top life sciences companies through transformation and innovation in technology.
ACTO Summit 2025
Join us in Chicago for the 2025 ACTO Summit, where Life Sciences leaders and innovators meet to uncover new features and explore the exponential impact of AI. Dive into ACTO’s cutting …
Engage: AI Roleplay, Coaching & Messaging for Field Teams | ACTO
Designed to improve customer engagement, CxZone by ACTO helps field teams master clinical conversations in a fast, flexible, and feedback-rich environment tailored to the unique nuances …
ACTO Omnichannel
Securely log in to ACTO Omnichannel to access AI-powered tools for enhancing field excellence and customer engagement in life sciences.
ACTO’S CXZONE WINS DUAL HONORS IN THE 2025 …
Dec 9, 2025 · ACTO is an Intelligent Field Excellence (IFE) platform built for life sciences that unifies human intelligence with empathetic AI to help Sales, Medical, Market Access, and …
ACTO LAUNCHES CXZONE: THE FIRST AI-SIMULATED ROLEPLAY …
Jul 24, 2025 · ACTO is an Intelligent Field Excellence (IFE) platform built for life sciences that unifies human intelligence with empathetic AI to help Sales, Medical, Market Access, and …